Candelotti Elena, De Luca Roberto, Megna Roberto, Maiolo Mariangela, De Vito Paolo, Gionfra Fabio, Percario Zulema Antonia, Borgatti Monica, Gambari Roberto, Davis Paul J, Lin Hung-Yun, Polticelli Fabio, Persichini Tiziana, Colasanti Marco, Affabris Elisabetta, Pedersen Jens Z, Incerpi Sandra
Department of Science, Roma Tre University, Rome, Italy.
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.
Front Cell Dev Biol. 2021 Apr 8;9:651492. doi: 10.3389/fcell.2021.651492. eCollection 2021.
Interaction between thyroid hormones and the immune system is reported in the literature. Thyroid hormones, thyroxine, T, but also T, act non-genomically through mechanisms that involve a plasma membrane receptor αvβ3 integrin, a co-receptor for insulin-like growth factor-1 (IGF-1). Previous data from our laboratory show a crosstalk between thyroid hormones and IGF-1 because thyroid hormones inhibit the IGF-1-stimulated glucose uptake and cell proliferation in L-6 myoblasts, and the effects are mediated by integrin αvβ3. IGF-1 also behaves as a chemokine, being an important factor for tissue regeneration after damage. In the present study, using THP-1 human leukemic monocytes, expressing αvβ3 integrin in their cell membrane, we focused on the crosstalk between thyroid hormones and either IGF-1 or monocyte chemoattractant protein-1 (MCP-1), studying cell migration and proliferation stimulated by the two chemokines, and the role of αvβ3 integrin, using inhibitors of αvβ3 integrin and downstream pathways. Our results show that IGF-1 is a potent chemoattractant in THP-1 monocytes, stimulating cell migration, and thyroid hormone inhibits the effect through αvβ3 integrin. Thyroid hormone also inhibits IGF-1-stimulated cell proliferation through αvβ3 integrin, an example of a crosstalk between genomic and non-genomic effects. We also studied the effects of thyroid hormone on cell migration and proliferation induced by MCP-1, together with the pathways involved, by a pharmacological approach and docking simulation. Our findings show a different downstream signaling for IGF-1 and MCP-1 in THP-1 monocytes mediated by the plasma membrane receptor of thyroid hormones, integrin αvβ3.
文献报道了甲状腺激素与免疫系统之间的相互作用。甲状腺激素,如甲状腺素(T4),还有三碘甲状腺原氨酸(T3),通过涉及质膜受体αvβ3整合素(胰岛素样生长因子-1(IGF-1)的共受体)的机制发挥非基因组作用。我们实验室之前的数据显示甲状腺激素与IGF-1之间存在相互作用,因为甲状腺激素会抑制IGF-1刺激的L-6成肌细胞的葡萄糖摄取和细胞增殖,且这些作用是由整合素αvβ3介导的。IGF-1还具有趋化因子的作用,是损伤后组织再生的重要因素。在本研究中,我们使用在细胞膜上表达αvβ3整合素的THP-1人白血病单核细胞,重点研究甲状腺激素与IGF-1或单核细胞趋化蛋白-1(MCP-1)之间的相互作用,通过使用αvβ3整合素及其下游途径的抑制剂,研究这两种趋化因子刺激的细胞迁移和增殖以及αvβ3整合素的作用。我们的结果表明,IGF-1是THP-1单核细胞中的一种有效趋化剂,可刺激细胞迁移,而甲状腺激素通过αvβ3整合素抑制这种作用。甲状腺激素还通过αvβ3整合素抑制IGF-1刺激的细胞增殖,这是基因组和非基因组效应之间相互作用的一个例子。我们还通过药理学方法和对接模拟研究了甲状腺激素对MCP-1诱导的细胞迁移和增殖的影响以及相关途径。我们的研究结果表明,在THP-1单核细胞中,由甲状腺激素的质膜受体整合素αvβ3介导的IGF-1和MCP-1具有不同的下游信号传导。